The Evolution of OFEV® (nintedanib) capsules

October 17 from 6:00 pm 8:00 pm CDT

Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

Please join Dr. Steven Nathan and Dr. Rodney Daniel as they provide their expert perspective on the evolution of OFEV. Faculty will review the pivotal safety and efficacy data for OFEV across three indications and recent guideline updates.

This is a non-CME event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2022 conference sessions. This event is not endorsed by CHEST and does not reflect the views or opinions of CHEST.

This presentation is sponsored by and made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc. Presentation content has been reviewed for consistency with FDA guidelines. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.

Speakers

Rodney S. Daniel, MD, MSCR
Rheumatologist
Oldsmar, Florida

Steven D. Nathan, MD, FCCP
Advanced Lung Disease, Lung Transplant & Inova Lung Services
Medical Director
Falls Church, Virginia